✦ LIBER ✦

Argatroban Dosing of Patients with Heparin-Induced Thrombocytopenia and an Elevated aPTT Due to Antiphospholipid Antibody Syndrome

✍ Scribed by Pendleton, R.

Book ID: 124156119
Publisher: Harvey Whitney Books Company
Year: 2006
Tongue: English
Weight: 65 KB
Volume: 40
Category: Article
ISSN: 1060-0280
DOI: 10.1345/aph.1G319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged half-life of argatroban in pat

Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia

✍ Uzma Athar; Juhi Husain; Jane Hudson; Jennie Lynch; Ajeet Gajra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Transitioning from Argatroban to Warfari

Transitioning from Argatroban to Warfarin in Heparin-Induced Thrombocytopenia: An Analysis of Outcomes in Patients with Elevated International Normalized Ratio (INR)

✍ John R. Bartholomew; Marcie J. Hursting 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 210 KB

Report of successful use of argatroban a

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

✍ Lewis, Bruce E. ;Iaffaldano, Robert ;McKiernan, Thomas L. ;Rao, Luxman ;Donkin, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) is a severe complication of heparin caused by an antibody response to the heparin-platelet factor 4 complex which results in severe thrombosis. Heparin rechallenge in HllTS patients carries a high risk of inducing thrombosis. Antithrom